Teicoplanin

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

ChemotherapyNeutropeniaNosocomial Infection

104 competitors in Chemotherapy

#DrugCompanyPhaseTrials

1

Taxol

Teva

Phase 3

202

Eloxatin

Teva

Phase 3

133

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3

294

Cytosar

Teva

Phase 3

115

Avastin

Roche

Phase 3

116

Vepesid

AAvyxa

Phase 3

227

Opdivo

Bristol-Myers Squibb

Phase 3

78

Imfinzi

AstraZeneca

Phase 3

79

Gemzar

Johnson & Johnson

Phase 3

510

Beyfortus

BeiGene

Phase 3

5Show 35 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Cholangitis1 trial

Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy

Completed·TTongji Hospital·Phase 4·NCT04370145·160 enrolled

Efficacy and Safety1 trial

Efficacy and Safety of Teicoplanin in CDAD

Terminated·Sanofi·Phase 4·NCT04003818·50 enrolled

Osteomyelitis1 trial

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Completed·Merck & Co.·Phase 2·NCT00428844·75 enrolled

Antibiotics1 trial

Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection

Withdrawn·—·Phase 1·NCT00925093

Knee Arthroplasty1 trial

Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty

Completed·UUniversity of Athens·Phase 4·NCT00719056·616 enrolled

10 more indications

Antibiotic1 trial

Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients

Completed·Sanofi·Phase 4·NCT00454272·197 enrolled

Osteoarticular Infections1 trial

Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study

Completed·—·Phase 2·NCT01815541·30 enrolled

Amputation1 trial

The Amputation Surgical Site Infection Trial (ASSIT)

Completed·HHull University Teaching Hospitals NHS Trust·Phase 4·NCT02018094·160 enrolled

Neutropenia1 trial

Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation

Completed·PPETHEMA Foundation··NCT00462878·392 enrolled

Soft Tissue Infections1 trial

Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections

Terminated·Novartis·Phase 3·NCT00430937·194 enrolled

Concentration1 trial

A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely

Unknown status·NNational Taiwan University Hospital·Phase 4·NCT00368498·20 enrolled

Nosocomial Infection1 trial

Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections.

Not yet recruiting·IInstitute of Liver and Biliary Sciences, India·N/A·NCT06818565·150 enrolled

Chemotherapy1 trial

Teicoplanin in Treating Septicemia in Patients Who Are Receiving Chemotherapy Through a Central Venous Catheter

Unknown status·CChildren's Cancer and Leukaemia Group·N/A·NCT00024453·1,360 enrolled

Surgical Site Infection1 trial

Does Teicoplanin Powder Use In Lumbar Instrumentation Surgery Reduce Surgical Site Infection

Unknown status·—·Phase 3·NCT04341831·120 enrolled

Bacterial Infections1 trial

A Randomized Trial Investigating the Superiority of TDM-optimized Teicoplanin Dosing Versus Standard of Care

Terminated·RRadboud University Medical Center·Approved·NCT05914467·54 enrolled

Details

Drug Info

Related News